Amgen Inc

AMGN

Log in to follow and get free email alerts when insiders file.

Sector

Biological Products, Except Diagnostic Substances

Industry

Drugs

Website

amgen.com

Recent Filings - SEC Insider Transactions (Form 3,4,5)

Date
  • today
  • yesterday
  • week
Price per share
Shares

Transaction Codes

File Date
 
Date
 
Company
 
Filer
 
Security
 
Shares
 
Price
 
$ Total
 
% Change
 
10%
 
Dir.
 
Off.
 
Code
 
View
 
SEC
 
SIC
 
SIC Group
 
SIC Division
 

      Rows per page:

      100

      0-0 of 0

    Buy / Sell (dollars)

    1 Month

    0%0%

    $0.00

    avg. $0.00

    $0.00

    avg. $0.00

    Buy/Sell Ratio

    0


    Transactions

    0

    Filers

    0

    3 Month

    0%0%

    $0.00

    avg. $0.00

    $0.00

    avg. $0.00

    Buy/Sell Ratio

    0


    Transactions

    3

    Filers

    3

    12 Month

    13.6%86.4%

    $4.84M

    avg. $4.84M

    $30.85M

    avg. $2.57M

    Buy/Sell Ratio

    0.157


    Transactions

    60

    Filers

    51

    24 Month

    16.8%83.2%

    $13.49M

    avg. $13.49M

    $67.00M

    avg. $2.79M

    Buy/Sell Ratio

    0.201


    Transactions

    147

    Filers

    122

    Filers

    CIK
    Name
    Title
    Last Transaction
    First Transaction
    Director
    Officer
    10% Own.
    Other
    1216478HOLLEY CHARLES M2021-08-102019-11-05
    1523102ISHRAK OMAR2021-08-102021-08-10
    1303141Kullman Ellen Jamison2021-08-102019-11-05
    1740205Druker Brian2021-05-202020-05-07
    1194256ECKERT ROBERT2021-05-192020-05-07
    1248617MILES AMY E2021-05-192020-07-27
    1464237Jacks Tyler2021-05-192020-05-07
    1690882Austin Wanda M2021-05-192020-05-07
    1503107Garland Greg C.2021-05-192020-05-07
    1375347Williams R Sanders2021-05-192019-11-07
    1216519SUGAR RONALD D2021-05-192019-11-07
    1816414Grygiel Nancy A.SVP & CCO2021-05-122020-08-03
    1396482Bradway Robert AChairman, CEO and President2021-05-032020-03-05
    1558616Johnston Lori AEVP, HR2021-04-282019-11-05
    1602343Piacquad DavidSVP, Business Development2021-03-222019-11-20